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Cluster determinant 4 (CD4) is a type I transmembrane glycoprotein of 58 kDa. It consists of an extracellular domain of 370 amino acids, a
short transmembrane region, and a cytoplasmic domain of 40 amino acids at the C-terminal end. We investigated the structure of the 62 C-terminal
residues of CD4, comprising its transmembrane and cytoplasmic domains. The five cysteine residues of this region have been replaced with serine
and histidine residues in the polypeptide CD4mut. Uniformly 15N and 13C labeled protein was recombinantly expressed in E. coli and purified.
Functional binding activity of CD4mut to protein VpU of the human immunodeficiency virus type 1 (HIV-1) was verified. Close to complete
NMR resonance assignment of the 1H, 13C, and 15N spins of CD4mut was accomplished. The secondary structure of CD4mut in membrane
simulating dodecylphosphocholine (DPC) micelles was characterized based on secondary chemical shift analysis, NOE-based proton–proton
distances, and circular dichroism spectroscopy. A stable transmembrane helix and a short amphipathic helix in the cytoplasmic region were
identified. The fractional helicity of the cytoplasmic helix appears to be stabilized in the presence of DPC micelles, although the extension of this
helix is reduced in comparison to previous studies on synthetic peptides in aqueous solution. The role of the amphipathic helix and its potentially
variable length is discussed with respect to the biological functions of CD4.
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For many years high resolution liquid state NMR studies on
integral membrane proteins (IMP) had been hampered by the
large size and prohibitively long rotational correlation times of
even the smallest liposomes, which arguably present the most
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protein U
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doi:10.1016/j.bbamem.2007.10.023stead, a variety of membrane mimicking conditions have been
explored that allow solubilization of individual membrane pro-
teins in an environment, that closely matches the physicochem-
ical conditions provided by the amphipathic lipid molecules in a
membrane while being suitable for solution NMR. These sys-
tems include organic solvents of reduced polarity, detergent
micelles, and small bicelles consisting of lipid and detergent,
and amphipathic polymers. Reviews on the available options for
membrane protein solubilization [1,2] and thorough evaluations
of a multitude of detergents for solution NMR studies on inte-
gral membrane proteins [3,4] have been published. Detergent
micelles turned out to be a good choice in many cases, allowing
collection of detailed structural information by solution NMR
that was compatible with solid state NMR data on the same
membrane-reconstituted proteins, if available, while preserving
important biological functions of the IMP in the micelle.
Reconstitution in detergent micelles or bicelles results in
particle size beyond 20 kDa even for the smallest IMPs. Ap-
plication of transverse relaxation-optimized [5] pulse sequences
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tergent, and spectrometers operating at ultra-high magnetic field
strength is therefore advantageous in most cases, providing
reduced line width and improved signal dispersion [6,7].
Uniform or selective isotope labeling of IMPs is also a basic
requirement for the use of traditional solution NMR protein
resonance assignment strategies based on triple resonance mul-
tidimensional experiments. Affordable production of isotope-
labeled material requires recombinant expression, purification,
and functional reconstitution of the IMP, which often presents a
demanding challenge [8].
High resolution NMR can address structure, dynamics, and
molecular interactions of IMPs at different levels. The chemical
shift values of selected resonances are rather sensitive to back-
bone torsion angles [9], i.e. the resonance assignment itself
contains already valuable information on the location of secon-
dary structure elements in the sequence. Proton–proton dis-
tances in the folded IMP can be derived from NOESY type
experiments and employed in molecular dynamics-based struc-
ture calculation protocols [10]. Confinement of the micelle- or
bicelle-embedded IMP in an asymmetric environment, e.g. a
stressed polyacrylamide gel [11,12], allows measurement of
residual dipolar couplings which provide bond vector orienta-
tion within the folded IMP and may assist the determination of
the three-dimensional structure of the protein backbone [13].
Periodic patterns (dipolar waves) in the measured couplings
along the amino acid sequence of the IMP report on location and
topology of helices [14]. High resolution NMRmeasurements of
relaxation times and [1H]–15N heteronuclear NOEs on micelle-
incorporated polypeptides provide site specific information on
dynamic properties of IMPs [15,16]. Liquid state NMR offers a
wide selection of approaches for detection, mapping, or in-depth
characterization of protein–protein interactions [17,18], many
of which can be extended to interaction analysis of micelle-
embedded IMPs in a straightforward manner.
The number of micelle reconstituted membrane proteins that
have been studied with high resolution NMR is increasing at a
rapid pace. They include IMPs with one [19], two [10] or more
membrane spanning helices [7] as well as β-barrel proteins [6].
Nevertheless, NMR characterization of IMPs still is a rather
complex task, requiring expression, purification, reconstitution,
and functional evaluation of the IMP as well as gathering and
interpretation of NMR data.
Here we report the recombinant production and initial char-
acterization of a cysteine substitution variant of the transmem-
brane and cytoplasmic domain of the human cluster determinant
4 (CD4). CD4 is a type I transmembrane glycoprotein with a
molecular weight of 58 kDa and consists of an extracellular
region of 370 amino acids, a short transmembrane region, and a
cytoplasmic domain of 40 amino acids at the C-terminal end.
The CD4 T-lymphocyte coreceptor belongs to the IgG-super-
family and participates in T-cell activation and signal transduc-
tion. Surface CD4 is expressed on T lymphocytes that recognize
antigens presented on class II major histocompatibility complex
(MHC II) molecules [20]. This specificity of CD4+ T-cells for
MHC II-expressing targets is based on direct interaction between
CD4 and MHC II [21]. CD4 associates with the T-cell receptorduring T-cell activation [22]. The mechanism by which CD4
participates in T-cell activation is thought to involve transduc-
tion of intracellular signals. The interaction of the lymphocyte
specific kinase (Lck), a Src-homologous tyrosine kinase, with
the cytoplasmic part of CD4 is a crucial step of the T-cell sig-
naling pathway [23].
In addition to these functions, CD4 serves as the major
receptor for human immunodeficiency virus (HIV) infection
[24,25]. The virus is internalized after binding of the viral en-
velope glycoprotein gp120 to the extracellular domain of CD4.
This leads to infection of the respective T helper cell, and the
production and release of new virions.
CD4 interacts via its cytoplasmic domain with viral proteins
Nef and Vpu. Vpu induces degradation of CD4 molecules in the
endoplasmatic reticulum (ER). This process requires both pro-
teins to be inserted into the same membrane compartment. The
CD4 sequence relevant for this activity is located between amino
acids 402–420 [26]. In contrast, Nef acts at the cell surface to
mediate the internalization and lysosomal degradation of CD4
[27,28]. Nef dependent down-regulation of CD4 is well un-
derstood on a cellular level. It appears to involve a whole set of
factors [29–34]. From mutational analysis it is known that
residues 407 to 418 in the cytoplasmic tail of CD4 are necessary
and sufficient for the down-regulation of CD4 by Nef [27,
28,35]. Especially, the dileucine motif at sequence positions 413
and 414 is required for the binding and down-modulation of
CD4 by Nef [36].
The three-dimensional structure of the complex between
CD4 cytoplasmic part and Lck residues 7 to 35 was determined
by NMR [37]. Structural information of CD4 complexes with
HIV Nef or VpU is not available yet.
2. Materials and methods
E. coli XL10-Gold ultracompetent cells (Stratagene) and E. coli C43(DE3)
competent cells (Avidis, Saint-Beauzire, France) were employed. The original
vector pTKK19xb/ub was a generous gift of Dr. Toshiyuki Kohno (Japan).
Custom synthesized DNA oligomers (primers) with codon usage optimized for
E. coli were obtained from BioTeZ (Berlin, Germany). Restriction enzymes
were from MBI Fermentas, PreScission protease from GE Healthcare.
Perdeuterated dodecylphosphocholine (DPC-d38), 2H2O,
13C-labeled glucose
and 15N-labeled ammonium chloride were purchased from Cambridge Isotope
Laboratories. The lipid 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) was from Avanti Polar Lipids, Inc. (Alabaster, AL, USA). HPLC grade
organic solvents were used. All other chemicals were graded analytical or better.
2.1. Cloning, expression, and purification of CD4mut
Plasmid pTKK19_CD4mut was designed for production of the cysteine
lacking, 70 residue CD4mut polypeptide as ubiquitin fusion. It is a modification
of the recently described vector pTKK19_CD4tmcyt [38] that is based on the
standard vector pTKK19xb/ub [39]. Site-directed mutagenesis was done by
overlap extension using the polymerase chain reaction (PCR) essentially as
described by Ho et al. [40]. In the first PCR, template pTKK19_CD4tmcyt was
incubated with the primers CD4_C394S/C397S-5′ and CD4_C420S/C422S/
C430H_Not_3′ to amplify a double stranded DNA fragment that includes the
coding sequence of the region CD4(390–433) with the five point mutations
C394S; C397S; C420S; C422S; and C430H. The second PCR utilized plasmid
pTKK19_CD4tmcyt as DNA template, the purified double stranded DNA
fragment provided the 3′ primer, and a 5′ primer was designed containing the
DNA complement of the N-terminus of the target sequence (PreScission and
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433), for details see Fig. 1 in [38]). The PCR-amplified DNA codes for the
cysteine-free CD4(372–433) mutant preceded by the two protease cleavage
sites. The PCR product was treated with T4 DNA polymerase to obtain blunted
5′ ends and finally digested with Not I. The resulting DNA fragment was ligated
into linearized pTKK19xb/ub plasmid (Mph1103 I digested, 3′ end blunted, 5′
end Not I restricted, and dephosphorylated) using the FastLink DNA ligation kit
(Biozym, Hessisch Oldendorf, Germany). The plasmid was amplified in E. coli
XL10-Gold ultracompetent cells. The DNA sequence of the obtained plas-
mid, referred to as pTKK19_CD4mut, was confirmed by DNA sequencing
(SEQLAB, Göttingen, Germany).
E. coli C43(DE3) competent cells were transformed with plasmid
pTKK19_CD4mut for expression of the fusion protein comprising an N-terminal
decahistidine tag, the 76 residue fusion partner yeast ubiquitin, a 14 residue linker
containing PreScission and Thrombin cleavage sites, and a 62 residue, cysteine-
free variant of a CD4 fragment resembling the transmembrane and cytoplasmic
domains of the CD4 receptor. Expression, purification, enzymatic cleavage, and
final isolation of the 70 residue CD4mut target protein (Fig. 1) largely followed
the recently published protocol for recombinant production of the corresponding
wild type CD4tmcyt fragment [38]. Briefly, the fusion protein was expressed at
high yield, is insoluble under native conditions, and was sequestered in inclusion
bodies. The fusion can be solubilized by sonification in buffer containing the
detergents Triton X-100 (0.5%, v/v) and cholic acid (0.5%, w/v) and is easily
purified in a one-step procedure usingNickel–NTA affinity chromatography. The
70 residue CD4mut is released by enzymatic cleavage with PreScission protease
in the presence of detergent, TCA-precipitated and purified to homogeneity using
reversed phase chromatography.
Uniformly 15N and 13C isotope-labeled CD4mut for NMR studies was
produced following the same protocol but growing bacteria in M9 minimal
medium [41] containing 15N-labeled ammonium chloride and/or 13C-labeled
glucose as the sole nitrogen and carbon sources, respectively.
2.2. Expression and purification of VpUcyt
VpUcyt is a soluble polypeptide corresponding to the C-terminal amino
acids 39 to 81 of the accessory membrane protein VpU of HIV-1 (isolate SF162,
group M, subtype B, SwissProt entry VPU_HV1S1) preceded by a GS
dipeptide. VpUcyt was recombinantly produced with an N-terminal GSTaffinity
tag using a pGEX-2T vector construct (GE Healthcare), enzymatically cleaved
with thrombin, purified to homogeneity, and lyophilized using standard pro-Fig. 1. Scheme of the polypeptide CD4mut. The 70 amino acid residue protein
CD4mut contains the transmembrane and cytoplasmic domains of human CD4,
comprising CD4 residues 372 through 433 (highlighted by a grey background,
numbering according to mature CD4 present after loss of the signal peptide [68])
with the five point mutations C394S, C397S, C420S, C422S, C430H, and an
additional N-terminal linker of eight residues (GPLVPRGS) remaining after
proteolytic cleavage of the fusion protein. Residue numbers referring to this
linker are enclosed in parenthesis. The cytoplasmic region of CD4 is highly
cationic at pH 6.2, charged side chains are indicated underneath the sequence.
The charge state of the histidines is somewhat ambiguous (expected pKa ∼6.5).
NMR secondary shift analysis of CD4mut in DPC micelles reveals formation of
two α-helices extending most likely from M372 to V395 (transmembrane helix)
and from M407 to R412 (cytoplasmic helix).tocols. The typical yield of purified VpUcyt was ∼12 mg/l of Luria–Bertani
(LB) culture.
2.3. NMR spectroscopy
Lyophilized CD4mut was solubilized at a concentration of 1 mM in∼330 μl
micelle solution (200 mM DPC-d38, 20 mM sodium phosphate, 150 mM NaCl,
0.02% (w/v) NaN3, 10% (v/v)
2H2O, pH 6.2). Sample homogeneitywas achieved
by vortex mixing. The sample was transferred to a (3×6) mm2 2H2O-matched
Shigemi S-tube (Varian Inc., Palo Alto, USA) after readjusting the pH to 6.2.
NMR spectra were recorded at 45 °C on Varian Unity INOVA instruments
operating at 1H Larmor frequencies of 600 and 800MHz, respectively, and using
cryogenically cooled, 5 mm 1H{13C,15N} triple resonance probes. The two
probes were equipped with an actively shielded three-axis pulsed field gradient
(PFG) or z-axis PFG coils, respectively. Experiments for sequential resonance
assignment were primarily recorded at 14.1 T, while NOESY spectra were
acquired at 18.8 T.
Resonance assignment of CD4mut in DPC micelles at 45 °C was based on a
combination of two- (2D) and three-dimensional (3D) NMR experiments: A
transverse relaxation-optimized (TROSY) [5] variant of the 1H,15N-HSQC [42],
a gradient-enhanced 1H,13C-HSQC [43], and 3D HNCA [44], HNCO [45],
HCACO [46], CBCA(CO)NH [47], CBCA(NH) [48], and HBHA(CBCACO)
NH [49] experiments. Additional spectra were acquired for side chain as-
signment: 3D H(C)CH-COSY [50], (H)CCH-TOCSY [51], H(C)CH-TOCSY
[50], and 2D (HB)CB(CGCD)HD and (HB)CB(CGCDCE)HE experiments [52].
Sequential and medium-range proton–proton distances were extracted from
gradient-enhanced 3D 15N NOESY–HSQC spectra [53] acquired with a mixing
time of 150 ms, and from 3D gradient-enhanced 13C-resolved HSQC–NOESY
spectra [54] recorded with a mixing time of 120 ms.
2.4. NMR data processing
NMR data were processed with NMRPipe [55]. The software package
CARA was used for spectral analysis and resonance assignment [56]. NOESY
spectra were analysed with RADAR, a software package that includes the
modules ATNOS [57] and CANDID [58] for automated NOESY peak picking
and assignment, respectively.
Deviation of observed chemical shifts of protein resonances from amino acid
specific random coil shifts, often referred to as secondary shifts (Δδ), is a
sensitive indicator of local secondary structure [59]. Secondary shift analysis of
CD4mut in DPCmicelles was based on tabulated random coil 13Cα and
1Hα shifts
determined by Schwarzinger et al. using Ac-GGXGG-NH2 peptides in 8 M urea
[60]. Amino acid sequence-dependent corrections of the random coil shifts were
applied [61]. Fractional helicity of a protein fragment with propensity for helix
formation is defined as the ratio of the mean observed secondary shift averaged
over the fragment and the mean secondary shift expected for a regular helix
[59,62]. Typical average secondary shifts in a helix are 2.6 ppm for 13Cα
(downfield shift) and −0.38 ppm for 1Hα resonances (upfield shift) [59].
2.5. Circular dichroism (CD) spectropolarimetry
CD spectra of 45 μMCD4mut in 20 mM sodium phosphate buffer (200 mM
DPC-d38, 0.02% (w/v) NaN3, pH 6.2) with and without 150 mM NaCl,
respectively, were recorded at 30, 40, and 50 °C. In addition, spectra of 50 μM
CD4tmcyt were acquired in the same buffer with 150 mM NaCl and sup-
plemented with 2 mM DTT at 30 °C. Far-UV CD data were collected between
260 and 185 nm on a Jasco J-810 spectropolarimeter (Jasco, Tokyo, Japan)
operating in continuous scan mode (scan speed 20 nm min−1; bandwidth 1 nm;
time constant 8 s; accumulation of 8 scans). A rectangular suprasil QS quartz cell
with a 1 mm optical path length (Hellma, Müllheim, Germany) was used.
Baseline scans of DPC solutions without protein were subtracted from the CD
curves.
Quantitative analysis of CD spectra was performed using the CDPro software
package [63] after converting the data to per residue differential molar
absorbance units (Δɛ/n in cm−1 M−1). The software includes the three methods
CONTIN/LL [64], SELCON3 [65], and CDSSTR [66]. All three fit the ex-
perimental CD data to a linear combination of CD spectra of proteins with known
crystal structures, referred to as basis set, but use different algorithms. The basis
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denatured proteins covering the wavelength range from 190 to 240 nm [63].
2.6. Analysis of interaction between CD4mut and VpUcyt
Reconstitution of the relatively small CD4mut into POPC membranes was
achieved by mixing the components in organic solvent, complete removal of the
solvent, and hydration with aqueous buffer. Appropriate amounts of POPC and
CD4mut were separately dissolved in a mixture of chloroform and methanol
(7:3, v/v), the solutions were combined in a test tube and the solvent was blown
off with a fine stream of nitrogen gas. The remaining thin film of lipid and
protein was redissolved in cyclohexane, frozen in liquid nitrogen, and lyo-
philized. Liposomes were formed by the addition of 1 ml of buffer (20 mM
sodium phosphate, 73 mMNaCl, pH 6.8) or of 1 ml VpUcyt solution in the same
buffer, respectively, followed by five freeze–thaw cycles and finally sonication
on ice using a Branson 250 sonifier equipped with a microtip (3×45 s, duty
cycle 50%, output control at 4).
The obtained small unilamellar liposomes with membrane-incorporated
CD4mut and bound VpUcyt were separated from the bulk of the aqueous buffer
containing various concentrations of the soluble VpUcyt by centrifugation.
Relative amounts of VpUcyt and CD4mut in the initial liposome dispersion as
well as in the pellet and supernatant fractions obtained after centrifugation were
monitored by reversed phase chromatography (RPC). In detail: following an
equilibration period of 1 h, two 100 μl aliquots of each of the initial 1 ml
liposome dispersions were reserved for RPC analysis. Samples were centrifuged
for 1 h at 20 °C and 340,000 ×g using an Optima TL-100 ultracentrifuge
equipped with a TLA-100.4 rotor (Beckman Coulter). The liposome pellet and
the supernatant were carefully separated. The pellet was resuspended in 0.8 ml
of the original buffer and 100 μl aliquots of both the supernatant and the
dispersed pellet fractions were withdrawn. The 100 μl aliquots were applied to
an analytical reversed phase EC 250/4.6 Nucleosil 300-7 C4 column (Macherey-
Nagel, Düren, Germany), which was mounted on an ÄKTA purifier system (GE
Healthcare) and had been equilibrated with buffer A (100% H2O, 0.1% (v/v)
TFA). Samples were eluted with a linear gradient from 100% buffer A to 100%
buffer B (80% acetonitrile, 20% H2O, 0.08% (v/v) TFA).Fig. 2. Analysis of CD4mut VpUcyt interaction in POPC membranes using
centrifugation followed by reversed phase chromatography. Dispersions of POPC
liposomes (10 mg POPC per sample, 1 ml each) containing varying amounts of
reconstituted CD4mut (0 mg— above; 0.5 mg— middle; 2 mg— below) were
incubated with 50 μM VpUcyt. Fully hydrated liposomes were separated from
supernatant by centrifugation. The composition of supernatant (left column) and
pellet fractions (right column) was analyzed by analytical RPC using a gradient of
buffers A and B (dashed line). Position of the VpUcyt (1), CD4mut (2), and POPC
(3) peaks are denoted underneath the chromatographic traces.3. Results
3.1. Protein production
The plasmid pTKK19_CD4mut allows very efficient recom-
binant production of the integral membrane protein CD4mut, a
cysteine substitution variant of CD4(372–433) comprising the
transmembrane and cytoplasmic domains of CD4. The simple
and very robust protocol for expression and purification of
CD4mut in E. coli provides relatively large amounts of isotope-
labeled protein that are sufficient for NMR characterization and
analysis of molecular interactions of the cytoplasmic domain of
CD4 with other proteins. The final yield of purified CD4mut
was ∼8 mg/l of bacterial culture, which compares favorably to
the ∼6 mg of CD4tmcyt per liter reported previously [38].
Notably, the yield of 15N- and 15N/13C-labeled CD4mut pro-
duced in isotope-labeled M9 medium is not significantly lower
than the protein yield in LB medium. The identity and high
purity of CD4mut and of its isotope-labeled variants was con-
firmed by SDS-PAGE, analytical RPC, and electrospray ion-
ization mass spectrometry.
3.2. Interaction between CD4mut and VpUcyt
The procedure used for membrane reconstitution of CD4mut
relies on component mixing in organic solvent. Successful in-corporation of CD4mut into the lipid membrane vesicles was
verified in initial tests without VpUcyt. A lyophilized mixture of
POPC and CD4mut was dispersed in 2H2O-based buffer
following our standard protocol. After centrifugation the li-
posome fraction was floating on top of the optically clear buffer.
Any aggregated CD4mut, if present, would be expected to
sediment on the bottom of the test tube. Liposome float and
buffer were carefully separated and analyzed by RPC. For this
purpose, the entire buffer fraction, but only 1/12-th of the redis-
persed liposome solution was applied to the column. As ex-
pected, the majority of the lipid and CD4mut is found in the
liposome float fraction. However, small CD4mut and POPC
peaks accounting for less than 10% of the total amount of
CD4mut and lipid, respectively, present in the initial sample
were detected in the buffer fraction, too. Notably, the ratio of the
integral peak intensities of POPC and CD4mut was nearly
identical in both fractions. Most likely, the small amount of lipid
and CD4mut detected in the buffer fraction reflects incomplete
separation of the liposome float from the clear buffer fraction by
decanting.
Fig. 2 shows the distribution of VpUcyt between buffer and
liposome pellet fractions in the absence (panels A and B) and
presence (C through F) of membrane-reconstituted CD4mut.
The concentration of VpUcyt was 50 μM in all samples. Indeed,
virtually identical VpUcyt amounts were detected in all RPC
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trifugation (data not shown). After separation, part of VpUcyt
is detected in the liposome fraction. A fully hydrated liposome
pellet consists of multilamellar arrays of alternating lipid mem-
branes and water layers and buffer filled morphological defects
[67]. A typical pellet contains ∼50 wt.% buffer. Even in the
absence of specific binding between VpUcyt and POPC an
appropriate fraction of the soluble VpUcyt is expected in the
pellet fraction in agreement with the small VpUcyt peak ob-
served in Fig. 2B.
The initial sample analyzed in Fig. 2C and D contained
0.5 mg CD4mut (corresponds to 62 μM CD4mut in the sample)
while Fig. 2E and F report on a sample with 2 mg (250 μM)
CD4mut in the POPC liposomes. The amount of VpUcyt in the
pellet clearly increases with raising CD4mut concentration in
the membrane (Fig. 2D vs. F), indicating specific binding
between the two proteins.
Separation ofmembrane-associatedVpUcyt from freeVpUcyt
by a simple centrifugation step in combination with RPC-based
quantification of VpUcyt and CD4mut in the two fractions can
serve as binding assay. The amount of VpUcyt nonspecifically
bound to the lipid membrane or simply trapped in the liposome
pellet (Fig. 2B) is apparently much smaller than the amount of
VpUcyt specifically attracted by 250 μM CD4mut in the mem-Fig. 3. Transverse relaxation-optimized 15N,1H-HSQC of uniformly 15N-labeled C
phosphate, pH 6.2, 150 mM NaCl) at 45 °C. All expected backbone amide 1HN–15N c
the one letter code. A close-up view of the strongly overlapped region between 8.35
insert in the upper right corner. Residues belonging to the transmembrane helix of CD
residues of CD4mut (P(−7); P(−4); P423; P432) give rise to cis–trans isomerization o
acid stretches in the immediate vicinity of the prolines. The majority of CD4mut con
S422 and P423, and S431 and P432. The correlations indicated in the HSQC spectru
exhibited additional but rather weak 1HN–15N correlations reflecting the weakly occ
are marked with asterisks in the spectrum.brane (Fig. 2F). Moreover, at 250 μM CD4mut there is more
VpUcyt in the pellet fraction (Fig. 2F) than in the supernatant
(Fig. 2E). If one assumes a one-to-one complex of VpUcyt and
CD4mut, the dissociation constant KD of this complex should be
on the order of 250 μMor lower. The lack of vectorial orientation
of liposome-reconstituted CD4mut contributes to the uncertainty
of this KD estimate. A significant fraction of CD4mut might not
be available for VpUcyt binding, simply because their cytoplas-
mic domain, which contains the VpU binding motif, is pointing
towards the interior of closed liposome particles.
3.3. NMR spectroscopy
The HSQC spectrum of CD4mut in DPC micelles (Fig. 3) is
strikingly similar to the previously publishedHSQCof CD4tmcyt
carrying five cysteines [38]. Pronounced 1H and 15N chemical
shift changes are limited to the five point mutations (C394S,
C397S, C420S, C422S, C430H) and to amino acids in the im-
mediate vicinity of these sites in the sequence.
Fig. 3 contains the assignment of the observed backbone
amide 1HN–15N cross-peaks of the CD4mut polypeptide. Resi-
dues of the transmembrane and cytoplasmic domains of human
CD4 are numbered according to their position in the mature
CD4 sequence without the signal peptide [68], while residueD4mut (1 mM) in detergent micelles (200 mM DPC-d38 in 20 mM sodium
orrelations of CD4mut (except for H399) have been identified and labeled using
and 8.05 ppm (1H) and 123 and 120 ppm (15N), respectively, is presented as an
4mut (M372 through V395) are marked by a grey background. The four proline
f X(i–1)–P(i) peptide bonds, resulting in multiple sets of cross-peaks for amino
formers adopt the trans form of the peptide bond connecting V(−5) and P(−4),
m reflect these trans conformers. Residues in the neighborhood of the prolines
upied cis form of the X(i–1)–P(i) peptide bonds. These additional cross-peaks
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tive numbers (cf. Fig. 1). All expected backbone correlations
were observed with the single exception of H399. The absence
of this 1HN–15N cross-peak is most likely a result of strong
spectral overlap in the corresponding region. CD4mut com-
prises four proline residues (P(−7); P(−4); P423; P432) that
may cause cis–trans isomerization of X(i–1)–P(i) peptide
bonds. The assigned resonances in Fig. 3 belong to the highly
occupied major subset of CD4mut conformers featuring trans
peptide bonds between V(−5) and P(−4), S422 and P423, as
well as S431 and P432 based on the observation of NOESY
cross-peaks between the δCH2 protons of the proline and the
1Hα protons of the preceding residue [69]. Weakly populated
subsets of additional peptide conformations carrying the cis
form of the peptide bond prior to one of the proline residues
give rise to separate low intensity 1HN–15N peaks of residues
that are close to the prolines in the polypeptide sequence. These
additional correlations are labeled by asterisks in the HSQC
spectrum in Fig. 3.
A carefully conducted initial screen of experimental
conditions like buffer composition, choice of detergent, and
temperature identified optimized conditions for acquisition of
high quality NMR spectra that were employed in the current
study. In particular, working at the elevated temperature of
45 °C provided the best spectral dispersion and narrowest
resonance line widths. A further increase in temperature beyond
45 °C was impractical due to protein stability issues and NMR
hardware limitations. The good resolution of the HSQC spec-
trum indicates feasibility of high resolution NMR studies on the
CD4 fragments in DPC micelles at 45 °C. The rotational cor-
relation time of micelle-embedded protein depends on the mass
of the entire complex, consisting of an estimated 50 to 60 DPC-
d38 monomers (aggregation number of DPC in water [70],
FW=390) and one CD4mut (FW=7.850), which amounts to a
complex of ∼30 kDa. Therefore, the TROSY version of theFig. 4. Strip plots of the correlations of backbone amides of residues M372 through
HNCA. Each amide is correlated with the intraresidue 13Cα chemical shift. Often an
observed, too. The dashed line traces the connectivity pattern. Amino acid residues1H,15N-HSQC shown in Fig. 3 gives narrower resonances than
an ordinary decoupled HSQC, however at the expense of a
longer acquisition time [5]. Heavy overlap of amide resonances
is observed close to 8.1 ppm, most likely due to the reduced
chemical shift dispersion of amide protons in α-helices and
unstructured regions. This signal degeneracy in two-dimen-
sional spectra clearly indicates a need for 15N/13C doubly la-
beled protein and NMR data sets of higher dimensionality for
resonance assignment and detailed NMR characterization of
CD4mut and of its molecular complexes.
Nearly complete resonance assignment was accomplished
for CD4mut in DPC micelles at 45 °C using a standard set of
multidimensional triple resonance experiments. Fig. 4 shows an
HNCA-based sequential walk through the particularly challen-
ging transmembrane domain of CD4mut. All backbone amide
(15N, 1HN) and 13Cα shifts of this domain could be unequi-
vocally assigned with this one 3D experiment despite strong
signal degeneracy in each of the three frequency domains. The
completeness of the resonance assignment of CD4mut can be
summarized as follows: Amide 1H (64 out of 65 are assigned),
amide 15N (64/65), backbone 13Cα (70/70),
1Hα (70/70), and
13CO (70/70), side chain 13C (189/189), 1H (375/419). The
resonance assignment of CD4mut in DPC micelles at 45 °C has
been deposited in the Biological Magnetic Resonance Data
Bank (BMRB), the accession code is 15479.
3.4. Secondary chemical shift analysis
The plot of 13Cα and
1Hα secondary chemical shifts of
CD4mut in DPCmicelles (Fig. 5) clearly reveals two continuous
stretches of downfield 13Cα and concomitant upfield
1Hα shifts
indicative of α-helix formation. The extension of the two helices
is estimated using Δδ 13Cα and Δδ
1Hα thresholds of 1.1 and
−0.1 ppm, respectively, resulting in helical segments 372–395
and 405–412 (based on Δδ 13Cα) or 372–396 and 407–412F393 of the transmembrane domain of CD4mut taken from a three-dimensional
additional, less intense correlation with the 13Cα shift of the preceding residue is
are specified below the strips.
Fig. 5. 13Cα and
1Hα secondary chemical shifts of CD4mut in DPCmicelles. The
conservative consensus of the extension of the two helical regions is shaded in
grey. A schematic diagram of the two helices is shown above. Solid bars
represent amino acids of the polypeptide that belong to the TM and cytoplasmic
domains of CD4, open bars are used for residues of the N-terminal linker region
which precedes the CD4 sequence in the 70 residue polypeptide CD4mut.
Reference random coil shifts corrected for sequence-dependent contributions
were derived from literature data [60,61].
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rently frayed rather than well defined. As a conservative con-
sensus of the chemical shift data we suggest a hydrophobic
transmembrane helix extending from M372 to V395 and a short
cytoplasmic helix from M407 to R412 (cf. Figs. 5 and 1). The
fractional helicity of these two regions is estimated from the
average of the secondary shifts measured. The TM helix is
characterized by ∼100% and ∼86% helicity based on the av-
erages of the experimental Δδ 13Cα and Δδ
1Hα values, re-Fig. 6. Summary of 1H–1H connectivities of CD4mut in DPC micelle solution (200 m
from NOESY spectra. For sequential HN(i)/HN(i+1) and Hα(i)/HN(i+1) cross-pe
Ambiguous or strongly overlapped cross-peaks have been omitted. Medium range NO
dense groupings of Hα(i)/Hβ(i+3), Hα(i)/HN(i+3), and Hα(i)/HN(i+4) cross-peaksspectively. The cytoplasmic helix has a lower helicity of ∼80%
(based on the meanΔδ 13Cα) and∼69% (based on the meanΔδ
1Hα). Assuming that the amino acid residues located outside the
two helical regions do not show any helical character (equivalent
to 0% helicity), we calculated the average helicity of the 70
residue CD4mut polypeptide. Overall helicities of ∼43% and
∼35% are derived for CD4mut from the Δδ 13Cα and Δδ 1Hα
analyses, respectively. Of course, these numbers provide only
very coarse estimates and must be interpreted with caution.
3.5. Characteristic NOE pattern reveals two helices
Regular secondary structure elements give rise to typical
NOE intensity pattern with sequential and medium-range
proton–proton NOE interactions that reflect short proton–
proton distances characteristic of these structures [69]. Fig. 6 is
a diagrammatic presentation of NOE connectivities of CD4mut
in DPC micelles at 45 °C. The data suggest the existence of two
helices in CD4mut. Most likely, the transmembrane helix ranges
from M372 to F392, but may extend up to R396 based on the
observed Hα(i)/Hβ(i+3) cross-peaks correlating F392 and
V395 as well as F393 and R396 and the considerable intensity
of the sequential HN(i)/HN(i+1) cross-peaks in the stretch from
I391 through S397. The shorter cytoplasmic helix very likely
extends from R406 to L414, but the exact limits of the helical
secondary structure may vary by one or two amino acid residues
on either side.
3.6. CD spectropolarimetry
The CD spectra of CD4mut and CD4tmcyt in DPC micelles
are very similar (Fig. 7A). They show local minima at∼208 and
∼220 nm, indicative of a significant fraction of helical struc-
ture. Measurements in buffer containing 150 mM NaCl are
confined to wavelength above 195 nm due to strong absorption
of chloride ions below 195 nm. However, even in salt free buffer
CD data at small wavelength were compromised by light
scattering caused by the micelles. Reference CD spectra of the
basis set SDP48 employed in the CDPro analysis are available
from 190 to 240 nm only. Therefore, spectral analysis was
restricted to the range from 195 to 240 nm. The three methodsMDPC-d38, 20 mM sodium phosphate, pH 6.2, 150 mMNaCl) at 45 °C derived
aks, the height of the boxes is proportional to the estimated NOE intensities.
E interactions are presented in the lower three rows. Simultaneous occurrence of
is typical for helical secondary structure.
Fig. 7. Far-UV CD spectra of CD4mut and CD4tmcyt in DPC micelles.
(A) CD4mut was studied in the presence (dotted line) and without 150 mMNaCl
(dashed line) at 30 °C. The spectrum of CD4tmcyt (solid line) was recorded with
150mMNaCl at 30 °C. (B)CD spectra of CD4mut inDPCmicelles with 150mM
NaCl show very little variation with temperature between 30 and 50 °C. Data
were recorded at 30 °C (dotted line), 40 °C (dashed line), and 50 °C (solid line).
2956 M. Wittlich et al. / Biochimica et Biophysica Acta 1768 (2007) 2949–2960CONTIN/LL, SELCON3, and CDSSTR used for quantitative
curve fitting of the CD spectra provided similar estimates of
secondary structure. The following distribution of conforma-
tions was obtained for CD4mut: 39 to 43% helix, 12 to 15% β-
strand, 16 to 19% turns, and between 23 and 31% unordered
conformations. The fractions of secondary structure estimated
in case of CD4tmcyt are very similar: 37 to 42% helix, 10 to
17% β-strand, 16 to 20% turns, and between 27 and 32%
unordered conformations. CDPro analysis was repeated with a
second basis set of reference spectra (SMP56, utilizing CD
spectra of 43 soluble and 13 membrane proteins [71]). Inter-
estingly, the above estimates of secondary structure content
were virtually unchanged.
Changing the temperature from 30 to 50 °C caused only
minor changes in the CD spectrum of CD4mut in DPC micelle
solution both in the presence and absence of 150 mM NaCl in
the buffer. CD spectra of CD4mut recorded at 30, 40, and 50 °C
with 150 mM NaCl in the micelle solution are presented in
Fig. 7B. Data analysis with CDPro indicated a reduction of
helical structure by no more than 4% with a concomitant in-
crease in unordered conformations upon raising the temperature
from 30 to 50 °C.
4. Discussion
Human immune cells displaying CD4 at their surface are the
primary target for infection with the human immunodeficiency
virus (HIV-1). CD4 serves as the main receptor for HIV entryinto the cell. The immunoglobulin-like ectodomain of CD4 is
specifically targeted by the trimeric surface glycoprotein gp120
of the virus. Immediately after infection the virus initiates
down-regulation of CD4 expression at the host cell surface by
several independent mechanisms [72]. Binding between CD4
and gp160, the precursor of HIV-1 envelope glycoprotein, traps
CD4 in the ER. Viral protein Nef enhances endocytosis of
surface exposed CD4 resulting in CD4 degradation in lyso-
somes. Viral protein U (VpU) is implicated in degradation of
newly synthesized CD4 in the ER by targeting CD4 to the
proteasomal pathway via ubiquitination. Both VpU and Nef
specifically interact with the C-terminal cytoplasmic domain of
CD4 [26,27]. In particular, the sequence L414-T419 in the
cytoplasmic domain of CD4 is required for VpU mediated
degradation of CD4 according to mutational studies [73].
All five cysteine residues within the C-terminal stretch of
amino acids 372 to 433 of human CD4 have been replaced in
the CD4mut polypeptide to simplify sample handling. These
five substitution mutations introduced in CD4mut are located
outside the known VpU and Nef target sequences on CD4
[27,28,35,73]. Cysteines 394 and 397 of CD4 are palmitolyla-
tion sites [74], C420 and C422 participate in a zinc coordinated
ternary CD4–Lck–Zn2+ complex [37]. The substitution of
C430 by a histidine was motivated by the occurrence of his-
tidine in murine CD4 at this position. The conformation of the
cytoplasmic and transmembrane domains of unbound CD4 in
membrane simulating DPC micelles is largely unaffected by
these conservative point mutations as demonstrated by the very
similar CD spectra (Fig. 7) and chemical shifts, apart from
the mutated residues themselves, of CD4mut (Fig. 3) and
CD4tmcyt (Fig. 6 in [38]). The observed binding of the soluble
Vpu fragment VpUcyt to membrane-reconstituted CD4mut
indicates biological relevance of the CD4mut construct for at
least one aspect of CD4 function and justifies the use of
CD4mut in future NMR-based studies of the structure and the
mode of interaction of the CD4 VpU complex.
Separation of CD4-bound and membrane-associated VpU
from free VpU in the buffer by centrifugation in combination
with RPC for quantitative analysis of the buffer and pellet
fractions provides a simple method to estimate binding affinity
between membrane-reconstituted CD4 and soluble VpU frag-
ments. Similar approaches have been used earlier to quantify
partition of small molecules between the lipid bilayer and the
water phase [75,76] or to study binding of peptides and proteins
to phospholipids vesicles [77,78].
The conformation of CD4mut in DPC micelles was studied
using analysis of secondary chemical shifts and NOE con-
nectivity patterns in concert with CD spectroscopy. Secondary
13Cα and
1Hα chemical shifts are particularly sensitive to
backbone torsion angles φ and ψ [9]. Systematic deviations of
these chemical shifts from random coil specific values over a
continuous stretch of amino acid residues provide a strong
indication for α-helix or β-sheet structures [59]. Intense se-
quential HN(i)/HN(i+1) NOEs in combination with intermedi-
ate intensity Hα(i)/HN(i+1), Hα(i)/HN(i+3) and Hα(i)/Hβ(i+3)
NOESY cross-peaks are a hallmark of regular helices [69].
However, the exact extension of secondary structure elements
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regions. This is particularly true if a protein adopts an ensemble
of structures. Both 13Cα and
1Hα chemical shifts as well as the
NOE connectivity pattern of CD4mut in DPC micelles indicate
formation of a long (transmembrane) and a short (cytoplasmic)
helix but with slightly different length (Figs. 5 and 6). The
secondary shifts of the residues between the two helices reveal
some helical character, but the Δδ values are below the
threshold for regular helices. The N- and C-termini of CD4mut
appear to be unstructured, however, turns or short strands might
go undetected in a secondary shift analysis. Fig. 8 shows a
schematic representation of the two observed helices in the
context of a detergent micelle.
Chemical shifts measured for an ensemble of conformers
undergoing fast exchange represent a time-weighted average of
the individual shifts. The average magnitude of the measured
secondary shift allows estimates of the fraction of conformers
that adopt a selected α-helix or β-sheet, respectively. Observa-
tion of just one set of chemical shifts in all NMR spectra of
CD4mut is compatible with either a unique conformation or fast
conformational exchange on the chemical shift time scale. The
transmembrane helix occurs in all or almost all CD4mut con-
formers according to the averaged 13Cα and
1Hα secondary
shifts, respectively. The fractional helicity of the short cyto-
plasmic helix is lower and amounts to 69 to 80%, indicating
some conformational flexibility in this region. The NOE pattern
of the cytoplasmic helix features Hα(i)/HN(i+1) connectivities
that are on average comparable in intensity or even stronger
than the HN(i)/HN(i+1) peaks in contrast to the corresponding
distances of 3.5 and 2.8 Å, respectively, in a regular α-helix.
This observation might indicate conformational averaging be-Fig. 8. Schematic representation of the transmembrane and cytoplasmic helices
of CD4mut in a detergent micelle. The ribbon diagram reflects the length of the
two helices derived from secondary shift analysis and the pattern of NOE-based
1H–1H distances. So far, no data on the relative orientation of the two helices
have been obtained. However, the amphipathic character of the cytoplasmic
helix suggests intimate contact with the polar head group region. The two
cylinders surrounding the helices symbolize the space requirement of the amino
acid side chains.tween helical and non-helical structures [79,80], in qualitative
agreement with a reduced fractional helicity of the cytoplasmic
helix derived from secondary shift analysis.
Fitting the CD spectrum of a protein to a linear combination
of CD spectra of proteins with known structure provides a
quantitative estimate of secondary structure elements in the
protein under study. A CD spectrum is based on all peptide
conformers present in the sample averaged over both the pep-
tide sequence and time.
In order to compare the results of secondary shift and CD
spectral analysis we estimated the overall helicity of the 70
residue CD4mut from the chemical shift data. The NMR-derived
overall helicity of∼35 to∼43% agrees well with the CD-based
estimate of ∼39 to 43% helical secondary structure. An im-
portant advantage of the more elaborate NMR analysis is the
precise localization of the helical regions in the amino acid
sequence, while the CD analysis has a higher sensitivity for
detection of turns and short β-strands. Indeed, the CD spectrum
of CD4mut in micelles indicates occurrence of a sizable fraction
of residues in turns (∼16 to 19%) andβ-strands (∼12 to 15%) in
addition to the dominating helices and a large number of residues
in unstructured regions.
The structure of the cytoplasmic domain of CD4 has been
studied previously by NMR and CD spectroscopy using the
soluble synthetic peptides CD4(403–419) [81] and CD4(396–
433) [37,82].Willbold andRösch identified anα-helix in aqueous
solution covering the sequence Gln403 to Arg412. The average
α-helical content of the 17 residue peptide was∼25%, indicating
that the helical structure was present in a subset of conformations
only. Wray et al. studied the 38 residue peptide representing the
entire cytoplasmic domain of CD4 inwater and in trifluoroethanol
(TFE) solution. In aqueous solution the polypeptide was found to
be unstructured [37,82]. Helical secondary structurewas observed
only in the presence of organic solvent and the helical content
increases with the concentration of TFE in buffer. At 50 vol.%
TFE an α-helix is observed that extends from Arg402 to Lys417
with an average fractional helicity of 62% in the central part
(Gln403 to Ser415) based on 1Hα secondary chemical shift ana-
lysis [82]. The cytoplasmic helix identified in the current study is
shorter (Met407 to Arg412) but has a higher fractional helicity
(∼69 to 80%). Anchoring the CD4mut peptide in a membrane
mimicking micelle does apparently stabilize this short helical
segment, perhaps this could be a result of the amphipathic
character of the cytoplasmic helix. Although our secondary shift
data and the NOE connectivity pattern indicate some helix
propensity for the residues flanking the cytoplasmic helix (Fig. 5)
the observed fractional helicity in these two regions is low.
Interestingly, computer-based sequence analysis predicts an α-
helical conformation of the CD4 fragment Arg402 to Thr419 [83]
supporting an intrinsic propensity of this sequence for helix
formation. It is conceivable that the cosolvent TFE, which is
known to stabilize α-helical secondary structure [84], causes an
extension of the cytoplasmic helix that does not occur in mem-
brane anchored CD4. Investigation of the CD4mut construct in
DPC micelles provides several advantages: the TM helix anchors
the molecule in the micelle and places the cytoplasmic domain in
the hydrated polar head group region. Importantly, the polar head
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lipids, which are abundant in membranes of eukaryotic cells.
In TFE-free aqueous solution, CD4(403–419) exhibits an
α-helical secondary structure for residues 403 to 412, followed
by a more extended conformation [81]. This helix ends at
position 412, identical to the cytoplasmic helix in the current
structure. Leucines 413 and 414 are known to be important as a
“dileucine” motif necessary for internalization of transmem-
brane proteins such as CD4, IgG Fc receptor and CD3 γ and δ
chains. Interestingly, the helix within the cytoplasmic part of
CD4 is prolonged in the complex with Lck(7–35) until residue
415 and both leucines (413 and 414) are reported to be covered
by the Lck part [37]. Comparison of CD4 structures in the
presence and absence of Lck(7–35) suggests that the presence
of Lck induces elongation of the membrane-proximal helix of
CD4 by another turn. This induces the side chains of leucines
413 and 414 to point towards the Lck part of the complex
which results in their shielding from any dileucine-targeting
machinery of the cell, and possibly also from Nef.
The sequence CD4(414–419), which is considered essential
for VpU binding [26,73], is not part of the cytoplasmic helix
observed in the current study. Nevertheless, the short helix
identified here is crucial for the interaction between CD4 and
VpU. Mutations of CD4 intended to provoke a distorting effect
on a putative α-helical conformation encompassing the region
CD4(407–411) abolished VpU-induced degradation of CD4
[85]. Notably, this sequence region closely matches the cyto-
plasmic helix CD4 (407–412) experimentally verified in the
current study. It is conceivable that binding of VpU to CD4
causes an extension of the cytoplasmic helix. Alternatively,
the length of this amphipathic helix might be sensitive to the
presence of electrically charged lipid head groups in the mem-
branes of the endoplasmatic reticulum or in themodel membrane
system employed. These questions will be addressed in future
studies using the CD4mut construct introduced here.
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